Detalhe da pesquisa
1.
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.
Diabetes Ther
; 12(2): 537-555, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423240
2.
Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.
PLoS One
; 13(2): e0191953, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408938
3.
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.
Diabetes Ther
; 9(3): 1149-1167, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29675798
4.
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.
Diabetes Ther
; 9(3): 1233-1251, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713961
5.
Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands.
Diabetes Ther
; 8(4): 753-765, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28523483
6.
Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom.
Prim Care Diabetes
; 11(3): 241-247, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28395938
7.
Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.
Pharmacoeconomics
; 34(9): 953-66, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27438706
8.
Resource use and outcomes associated with initiation of injectable therapies for patients with type 2 diabetes mellitus.
Drugs Context
; 4: 212269, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25657811
9.
American Diabetes Association--68th Scientific Sessions. Results for ACCORD, ADVANCE and other clinical trials.
IDrugs
; 11(8): 550-2, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18683085
10.
American Diabetes Association--68th Scientific Sessions. Preclinical and early clinical data with promising agents.
IDrugs
; 11(8): 553-5, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18683086
11.
American Diabetes Association--68th Scientific Sessions. Clinical trial results.
IDrugs
; 11(8): 556-8, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18683087
12.
Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
IDrugs
; 11(11): 841-5, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19024888
13.
BioPartnering Europe--16th annual conference.
IDrugs
; 11(12): 880-3, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19051148
14.
Digestive Disease Week 2009. Turning science into medicine: Part 2.
IDrugs
; 12(8): 471-3, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19629876
15.
Digestive Disease Week 2009. Turning science into medicine: Part 1.
IDrugs
; 12(8): 467-70, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19629875